Molinalogo

Measure

2023 Rate

2023 Goal

2024 Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

54.05%

64.90%

52.87%

66.15%

Annual Dental Visits (ADV) Total

45.09%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

41.93%

46.74%

32.68%

48.16%

Appropriate Testing for Pharyngitis (CWP)

67.15%

77.56%

76.41%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

91.55%

93.08%

89.74%

91.27%

Asthma Medication Ratio (AMR) Total

57.77%

69.41%

66.32%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

57.95%

66.19%

61.52%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

49.15%

68.61%

66.91%

71.78%

Breast Cancer Screening (BCS)

64.93%

55.25%

Breast Cancer Screening (BCS-E)

64.93%

54.94%

64.85%

56.66%

Cervical Cancer Screening (CCS)

69.10%

59.85%

67.10%

60.10%

Childhood Immunization Status (CIS) Combination #10

39.17%

35.04%

35.28%

31.32%

Chlamydia Screening in Women (CHL) Total

75.78%

61.07%

76.55%

61.46%

Controlling High Blood Pressure (CBP)

53.77%

65.45%

67.40%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

76.64%

80.86%

79.12%

83.51%

Eye Exam for Patients With Diabetes (EED)

60.83%

56.20%

55.23%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

19.68%

27.73%

19.70%

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

36.18%

46.35%

37.94%

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

45.76%

41.03%

50.76%

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

35.60%

37.31%

35.39%

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

55.66%

57.90%

65.45%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

55.24%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

39.42%

55.72%

59.61%

59.64%

Immunizations for Adolescents (IMA) Combination #2

45.26%

38.93%

48.66%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

14.79%

16.94%

14.97%

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

42.16%

38.80%

44.28%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

39.70%

39.01%

42.72%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

NQ

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

39.16%

31.93%

36.71%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

69.58%

75.79%

62.69%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

85.17%

86.96%

76.54%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

65.45%

≤ 92.72%

89.45%

≤ 91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

82.97%

86.86%

86.13%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

79.81%

80.78%

83.94%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

25.84%

25.81%

Prenatal Immunization Status (PRS-E) Combination Rate

25.84%

25.81%

24.33%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

3.83%

≤ 2.45%

3.16%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

81.00%

81.64%

82.56%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

63.48%

73.63%

60.22%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

69.08%

67.07%

69.05%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

55.03%

70.37%

55.07%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

70.56%

63.89%

73.51%

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

75.15%

75.44%

72.70%

72.74%

Use of Opioids at High Dosage (HDO)

2.42%

≤ 2.19%

3.02%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

0.54%

≤ 0.87%

0.20%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

81.27%

83.21%

87.35%

86.20%